Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi

Blood (2021) 138 (Supplement 1): 2487.

https://doi.org/10.1182/blood-2021-150337

Published: 2021

Journal Articles

A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients

Blood (2015) 126 (23): 2930.

https://doi.org/10.1182/blood.V126.23.2930.2930

Published: 2015

Journal Articles

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

María Victoria Barbado, PhD, Mayte Medrano, Jose Ignacio Piruat, PhD, Ivan Valle, Teresa Caballero, PhD, Isabel Álvarez, Jose Antonio Perez-Simón, MDPhD

Blood (2014) 124 (21): 4724.

https://doi.org/10.1182/blood.V124.21.4724.4724

Published: 2014

Journal Articles

Multicenter Study with Mbvd Regimen in Elderly or Younger Patients with Cardiac Disorders Affected By Hodgkin’s Lymphoma. a Phase II Study on Behalf of the Fondazione Italiana Linfomi (FIL)

Flavia Salvi, MD, Michele Spina, MD, Alessandro Pulsoni, MD, Sergio Storti, MD, Alessandra Tucci, MD, Marianna Chiozzotto, MD, Stefania Massidda, MD, Isabel Alvarez, MD, Caterina Stelitano, MD, Anna Marina Liberati, Valentina Lenti, Manuela Ceccarelli, MD, Alessandro Levis, MD

Blood (2014) 124 (21): 1732.

https://doi.org/10.1182/blood.V124.21.1732.1732

Published: 2014

Journal Articles

Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell

Alicia Baez, Jose Ignacio Piruat, Ph.D, Teresa Caballero-Velazquez, María Victoria Barbado, Ph.D, Isabel Alvarez-Laderas, Africa Millan-Ucles, Mayte Medrano, Estefania Garcia-Guerrero, Luis Ignacio Sanchez-Abarca, Ph.D., Ildefonso Espigado, Jose Antonio Perez-Simón, MD, PhD

Blood (2013) 122 (21): 1892.

https://doi.org/10.1182/blood.V122.21.1892.1892

Published: 2013

Journal Articles

Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals

Alicia Baez, Isabel Alvarez-Laderas, Jose Ignacio Piruat, Ph.D, Teresa Caballero-Velazquez, Africa Millan-Ucles, María Victoria Barbado, Ph.D, Mayte Medrano, Estefania Garcia-Guerrero, Luis Ignacio Sanchez-Abarca, Ph.D., Jose Antonio Perez-Simón, MD, PhD, Ildefonso Espigado

Blood (2013) 122 (21): 4893.

https://doi.org/10.1182/blood.V122.21.4893.4893

Published: 2013

Journal Articles

Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)

Blood (2011) 118 (21): 777.

https://doi.org/10.1182/blood.V118.21.777.777

Published: 2011

Journal Articles

Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results From a Study of the Intergruppo Italiano Linfomi (IIL)

Francesco Merli, MD, Stefano Luminari, MD, Giuseppe Rossi, MD, Caterina Mammi, PhD, Luigi Marcheselli, Dr, Isabel Alvarez, MD, Alessandra Tucci, MD, Caterina Stelitano, MD, Fiorella Ilariucci, MD, Maurizio Musso, MD, Luca Baldini, MD, Alberto Fragasso, MD, Annalisa Chiappella, MD, Massimo Federico, MD

Blood (2010) 116 (21): 1771.

https://doi.org/10.1182/blood.V116.21.1771.1771

Published: 2010

Journal Articles

Rituximab (R) Maintenance Versus Observation After Short Term Chemoimmunotherapy R-FND as First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Updated Results and Safety of the Maintenance of An Intergruppo Italiano Linfomi (IIL) Randomized Trial.

Blood (2009) 114 (22): 1706.

https://doi.org/10.1182/blood.V114.22.1706.1706

Published: 2009

Journal Articles

Brief Chemoimmunotherapy Rituximab (R)-FND ± R Maintenance as First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Preliminary Analysis of a Prospective Randomized IIL Trial

Blood (2008) 112 (11): 834.

https://doi.org/10.1182/blood.V112.11.834.834

Published: 2008

Journal Articles

Defibrotide Low-Dose Continuous Infusion from Day +1 Until Day +21 after Allogeneic Stem Cell Transplantation as Prophylaxis of Veno-Occlusive Disease (VOD) of the Liver. A Single Centre Experience.

Alessandro Bonini, Paolo Avanzini, Luciano Masini, Francesco Merli, Fiorella Ilariucci, Barbara Gamberi, Alessia Tieghi, Isabel Alvarez, Annalisa Immovilli, Annalisa Pilia, Luigi Gugliotta

Blood (2007) 110 (11): 4927.

https://doi.org/10.1182/blood.V110.11.4927.4927

Published: 2007

Journal Articles

Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation ± Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638)

Blood (2007) 110 (11): 1278.

https://doi.org/10.1182/blood.V110.11.1278.1278

Published: 2007

NARROW

Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi

A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

Multicenter Study with Mbvd Regimen in Elderly or Younger Patients with Cardiac Disorders Affected By Hodgkin’s Lymphoma. a Phase II Study on Behalf of the Fondazione Italiana Linfomi (FIL)

Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell

Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals

Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)

Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results From a Study of the Intergruppo Italiano Linfomi (IIL)

Rituximab (R) Maintenance Versus Observation After Short Term Chemoimmunotherapy R-FND as First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Updated Results and Safety of the Maintenance of An Intergruppo Italiano Linfomi (IIL) Randomized Trial.

Brief Chemoimmunotherapy Rituximab (R)-FND ± R Maintenance as First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Preliminary Analysis of a Prospective Randomized IIL Trial

Defibrotide Low-Dose Continuous Infusion from Day +1 Until Day +21 after Allogeneic Stem Cell Transplantation as Prophylaxis of Veno-Occlusive Disease (VOD) of the Liver. A Single Centre Experience.

Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation ± Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only